Friday 6 November 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue: +11.2%
EPS: +0.58%
Free cash flow: −52.9%
Total debt: +0.31%

Quarter to September 2026, against a year earlier

79.50 4.96 −5.87%

Follow DXCM

Alert me

Market cap: $31.5B
P/E: 30.6×
Fwd P/E: 31.8×
Dividend yield: —
F-score: 8/9
Altman Z: 6.43
Beneish M: −2.70
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

DexCom, Inc. 10-Q filed Oct 30, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed Oct 30, 2025 · accepted 5:19 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 30, 2025: 1 modified